Home/ Supplements/ Resveratrol/ ilLuminol Reservatrol Formula 250

ilLuminol Reservatrol Formula 250

product on market Capsule LifeLink Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines trans-resveratrol and quercetin, which have moderate evidence for supporting antioxidant activity and cellular health. Piperine is included to potentially enhance the bioavailability of these compounds. Overall, research evidence for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for ilLuminol Reservatrol Formula 250
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 167.0mg (311 products) 183 studies (A:0, B:65)
250 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Piperine
10 mg

Other Ingredients

Microcrystalline Cellulose Gelatin
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: 1-3 capsules daily or as directed by a health care professional.

Additional Information

Keep frozen until opened, then refrigerate.

ilLuminol is a high-potency resveratrol supplement with bioavailability enhancers. Resveratrol has attracted strong interest from researchers looking for ways to prevent cancer, heart disease, and other age-related conditions, including aging itself.

Metadata

Product Details

UPC / SKU6 39793 60100 4
DSLD Entry Date2012-10-01
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID11849
Data Updated2026-04-11
Research

Research Evidence

193
Research Sources
55
Avg Quality
92
Systematic Review
83
Meta Analysis
9
Rct
7
Clinical Trial
1
Openfda Safety
B Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2018 PubMed DOI
B Resveratrol for adults with type 2 diabetes mellitus
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies
Systematic Review Critical reviews in food science and nutrition 2022 PubMed DOI
B Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials
Meta Analysis European journal of clinical nutrition 2019 PubMed DOI
B Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta-analysis
Meta Analysis Annals of the New York Academy of Sciences 2019 PubMed DOI
B The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2020 PubMed DOI
B Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis
Meta Analysis Critical reviews in food science and nutrition 2022 PubMed DOI
B Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2015 PubMed DOI
B Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis
Meta Analysis Nutrients 2020 PubMed DOI
View all evidence for Resveratrol →
Compare

Similar Products

View all Resveratrol products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.